Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapyYoshio Nakamura, Naoya Yamazaki, Shigehisa Kitano et al.|Oncotarget|2016Cited by 160
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patientsYasuhiro Nakamura, N. Yamazaki, Kenjiro Namikawa et al.|Annals of Oncology|2020Cited by 140
Updates on the Systemic Treatment of Advanced Non-melanoma Skin CancerKeiji Tanese, Takeru Funakoshi, Yoshio Nakamura et al.|Frontiers in Medicine|2019Cited by 45
Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanomaYuko Baba, Keiji Tanese, Takeru Funakoshi et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 37
Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanomaKeitaro Fukuda, Yutaka Kawakami, Takeru Funakoshi et al.|Melanoma Research|2017Cited by 29